Mechanism of Action of Glyceryl Trinitrate

Introduction

Glyceryl Trinitrate (GTN), commonly known as nitroglycerin, is an organic nitrate widely used in the treatment of angina pectoris and acute coronary syndromes. It acts primarily as a vasodilator by releasing nitric oxide (NO), which relaxes vascular smooth muscle.

GTN reduces myocardial oxygen demand by decreasing preload and also improves coronary blood flow through vasodilation. Because of its rapid onset of action, it is frequently used in sublingual formulations for acute angina relief.

Understanding the mechanism of glyceryl trinitrate is important for pharmacology examinations such as USMLE, NEET PG, FMGE, PLAB, INICET, NCLEX, and MCCQE.

MOA of Glyceryl Trinitrate — Mechanism of Action of Glyceryl Trinitrate

Glyceryl Trinitrate clinical pharmacology — MOA of Glyceryl Trinitrate

Flowchart of Mechanism of Action of Glyceryl Trinitrate — MOA of Glyceryl Trinitrate flowchart

Mechanism of Action (Step-wise)

Glyceryl trinitrate produces vasodilation through nitric oxide mediated smooth muscle relaxation.

Step 1: Enzymatic conversion to nitric oxide
Glyceryl trinitrate is converted within vascular smooth muscle cells to nitric oxide (NO), primarily by mitochondrial aldehyde dehydrogenase.

Step 2: Activation of guanylate cyclase
Nitric oxide activates soluble guanylate cyclase in vascular smooth muscle cells.

Step 3: Increase in cyclic GMP
Activation of guanylate cyclase increases intracellular cyclic guanosine monophosphate (cGMP).

Step 4: Smooth muscle relaxation
Elevated cGMP activates protein kinase G, leading to decreased intracellular calcium and relaxation of vascular smooth muscle.

Step 5: Venous vasodilation predominance
GTN predominantly dilates veins, reducing venous return to the heart.

Step 6: Reduction of cardiac workload
Reduced venous return decreases preload and myocardial oxygen demand.

Overall effect:
Vasodilation leading to decreased preload, improved coronary perfusion, and relief of angina.

Important pharmacology concept:
Organic nitrates mainly reduce myocardial oxygen demand rather than significantly increasing oxygen supply.

Pharmacokinetics

Absorption:
Rapidly absorbed through sublingual mucosa, transdermal patches, and oral formulations.

First pass metabolism:
Extensive hepatic metabolism when taken orally.

Distribution:
Widely distributed in vascular tissues.

Metabolism:
Metabolized mainly in the liver by nitrate reductases.

Excretion:
Metabolites are excreted in urine.

Onset and duration:

Sublingual: onset within minutes
Transdermal: prolonged action

Clinical Uses

Acute angina pectoris
Chronic stable angina
Acute coronary syndromes
Acute heart failure with pulmonary edema
Hypertensive emergencies (intravenous form)

Sublingual nitroglycerin is commonly used for immediate relief of anginal pain.

Adverse Effects

Common adverse effects:

Headache due to cerebral vasodilation
Flushing
Hypotension
Dizziness

Serious adverse effects:

Reflex tachycardia
Severe hypotension

Important interaction:

Concomitant use with phosphodiesterase-5 inhibitors (e.g., sildenafil) can cause life threatening hypotension.

Tolerance:
Continuous nitrate exposure may lead to nitrate tolerance.

Comparative Analysis

Feature	Glyceryl Trinitrate	Beta Blockers	Calcium Channel Blockers
Mechanism	NO mediated vasodilation	Reduce heart rate and contractility	Reduce calcium influx
Primary effect	Reduce preload	Reduce myocardial oxygen demand	Vasodilation and reduced contractility
Onset	Rapid (sublingual)	Moderate	Moderate
Use in acute angina	Yes	No	Limited
Major adverse effect	Headache, hypotension	Bradycardia	Peripheral edema

Explanation:

Glyceryl trinitrate reduces myocardial oxygen demand primarily by venous vasodilation and reduction of preload. Beta blockers reduce oxygen demand by lowering heart rate and contractility. Calcium channel blockers act by decreasing calcium entry into cardiac and vascular smooth muscle, leading to vasodilation and reduced myocardial workload.

MCQs

Glyceryl trinitrate acts mainly by releasing:
a) Dopamine
b) Nitric oxide
c) Serotonin
d) Acetylcholine

Answer: b) Nitric oxide

Nitric oxide activates:
a) Adenylate cyclase
b) Guanylate cyclase
c) Phospholipase C
d) Protein kinase A

Answer: b) Guanylate cyclase

Increased cGMP leads to:
a) Smooth muscle contraction
b) Smooth muscle relaxation
c) Increased calcium influx
d) Increased sodium influx

Answer: b) Smooth muscle relaxation

Glyceryl trinitrate mainly causes:
a) Arterial constriction
b) Venous dilation
c) Bronchoconstriction
d) Increased heart rate directly

Answer: b) Venous dilation

Reduction of preload decreases:
a) Cardiac output only
b) Myocardial oxygen demand
c) Renal blood flow
d) Blood viscosity

Answer: b) Myocardial oxygen demand

Sublingual nitroglycerin is used for:
a) Hypertension only
b) Acute angina attack
c) Diabetes
d) Asthma

Answer: b) Acute angina attack

Common adverse effect of nitrates:
a) Headache
b) Bradycardia
c) Hyperglycemia
d) Hypokalemia

Answer: a) Headache

Concomitant use with sildenafil may cause:
a) Severe hypertension
b) Severe hypotension
c) Hyperglycemia
d) Renal failure

Answer: b) Severe hypotension

GTN reduces myocardial oxygen demand mainly by:
a) Increasing heart rate
b) Increasing contractility
c) Reducing preload
d) Increasing blood viscosity

Answer: c) Reducing preload

Enzyme involved in GTN bioactivation:
a) Aldehyde dehydrogenase
b) Cyclooxygenase
c) Lipoxygenase
d) Monoamine oxidase

Answer: a) Aldehyde dehydrogenase

FAQs

How does glyceryl trinitrate relieve angina?
By releasing nitric oxide, which relaxes vascular smooth muscle and reduces cardiac workload.
Why is sublingual administration preferred for acute angina?
Because it bypasses first pass metabolism and produces rapid onset of action.
Why do nitrates cause headache?
Due to dilation of cerebral blood vessels.
What causes nitrate tolerance?
Continuous exposure reduces responsiveness of vascular smooth muscle to nitrates.
Why should nitrates not be combined with sildenafil?
Because both increase cGMP levels, causing severe hypotension.
Do nitrates increase oxygen supply to the heart?
Their primary effect is reducing oxygen demand rather than significantly increasing supply.

References

Goodman & Gilman’s Pharmacological Basis of Therapeutics
https://accessmedicine.mhmedical.com/book.aspx?bookID=2189

Katzung BG. Basic and Clinical Pharmacology
https://accessmedicine.mhmedical.com/book.aspx?bookID=2249

Tripathi KD. Essentials of Medical Pharmacology
https://jaypeedigital.com/book/9789354651970

Harrison’s Principles of Internal Medicine
https://accessmedicine.mhmedical.com/book.aspx?bookID=3095

Harsh Singh Rajput

I am pursuing MBA in pharmaceutical management from NIPER Hyderabad with a strong academic record and proven success in national-level pharmacy entrance exams. I secured AIR 61 in NIPER 2024 (MS/M.Pharm) and AIR 27 in NIPER MBA, along with AIR 147 in GPAT 2024 and AIR 907 in GPAT 2023. I also achieved AIR 6 in AIIMS CRE-2025 for Drug Store Keeper and was selected as a Pharmacist (AIR 61) for ESIC. Additionally, I was the Runner-Up in Round 2 of the EY Case Study Competition.
At PharmacyFreak.com, I aim to guide future pharmacists through expert content, exam strategies, and insightful resources based on real experience and academic excellence.
Mail- harsh@pharmacyfreak.com